Vildagliptin Tablets

Form: Tablets

Strength: 50 mg

Reference Brands: Galvus (EU)

Category: Diabetes

Vildagliptin is a DPP-4 inhibitor used to manage type 2 diabetes mellitus by enhancing incretin levels, improving insulin secretion, and reducing glucagon production. While not FDA-approved in the USA, it holds EMA approval and is widely marketed in the EU under brand names like Galvus and Galvus Met. Vildagliptin is available as monotherapy or in fixed-dose combinations with metformin. EU regulatory bodies emphasize its safety, tolerability, and cardiovascular neutrality. Pharmatradz.com connects global buyers and suppliers to EU-approved vildagliptin formulations, enabling seamless B2B transactions in the regulated pharmaceutical market.